psychedelic therapy

The Potential for Psychedelic Treatment for Veterans

From the fallout of COVID-19 to therapy becoming more accepted and recognized and the rise of new treatments, mental health has become a mainstream conversation. But one subset with specific needs remains neglected: Veterans. Veterans Lack Support When Returning Home From Deployment Havn Life Director and Veteran Tim Laidler was deployed to Afghanistan in 2008. […]

The Potential for Psychedelic Treatment for Veterans Read More »

The Effects of Psychedelics on Relationships

By Catherine Kakenya Psychedelics are believed to have been used by Indigenous cultures for thousands of years. More scientific research of them began in the 1940s, and studies included treatment of patients with alcohol disorder. Lysergic acid diethylamide (LSD) was discovered to uncover long-lost memories and help people to revisit traumatic memories and see them

The Effects of Psychedelics on Relationships Read More »

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine

ATMA and SYNTAC Institute Collaborate to Submit a Group Application for Section 56 Exemption from Health Canada to Access Psychedelic Therapy ATMA Journey Centers Inc. (ATMA), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine Read More »

Mount Sinai Health System Launches Center for Psychedelic Research

The Icahn School of Medicine at Mount Sinai has launched a new center for psychedelics research. The Center for Psychedelic Psychotherapy and Trauma Research pursues a multipronged clinical and research approach to discovering novel and more efficacious therapies for post-traumatic stress disorder (PTSD), depression, anxiety, and other stress-related conditions in the veteran and civilian population. The Center

Mount Sinai Health System Launches Center for Psychedelic Research Read More »

Effects of Low-Dose LSD on Mood and Cognition

By Sandra Nomoto Selective, Beneficial Effects on Mood and Cognition Observed A study aimed to determine whether a low dose of Lysergic acid diethylamide (LSD) positively affects cognition and mood, and at which dose these effects occur. It was recently published in the journal European Neuropsychopharmacology. Controlled research on the efficacy of microdosing is scarce.

Effects of Low-Dose LSD on Mood and Cognition Read More »

MDMA-Assisted Psychotherapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness

Future Clinical Trials With Larger Sample Sizes and More Diverse Populations Are Warranted to Study the Application of MDMA-Assisted Psychotherapy for Treating Anxiety A peer-reviewed study published today in the journal Scientific Reports provides sufficient evidence to support further research into the palliative effects of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. The pilot study, sponsored

MDMA-Assisted Psychotherapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness Read More »

Common Views and Attitudes Towards Psychedelic Medicines and Therapies

By Candice Folkard Psychedelics have a rich history, from use amongst indigenous people, guided by ancient knowledge passed on through centuries of traditional practices, to their discovery by modern science leading into a hampering period of criminalisation and finally through to a resurgence of research into uses in modern psychological treatment. A brief insight into

Common Views and Attitudes Towards Psychedelic Medicines and Therapies Read More »

Study Shows Psychedelic Treatment with Psilocybin Relieves Major Depression

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up. A compound found in so-called

Study Shows Psychedelic Treatment with Psilocybin Relieves Major Depression Read More »

Can psychoactive plants help terminally ill patients?

By Patrick Bailey Changing Attitudes Toward Psychedelics Benefit the Terminally Ill The prejudices of yesterday do not have the same hold on people today. Psychoactive drugs have a long history of negative publicity and incredibly Draconian law enforcement practices. The most common one is cannabis, but the current generation of Americans coming of age has

Can psychoactive plants help terminally ill patients? Read More »

Field Trip Launches Therapeutic Program for Combat Veterans, First Responders, and Healthcare Workers

New Program Offers Psychedelic-Assisted Psychotherapy That Benefits Frontliners and Others in High-Pressure Occupations Field Trip Psychedelics Inc., a company doing work in psychedelics and psychedelic-enhanced psychotherapy, announced the launch of Field Trip Basecamp, a long-term program focused on serving individuals suffering from debilitating mental health issues as a result of high-pressure occupations. The immediate focus

Field Trip Launches Therapeutic Program for Combat Veterans, First Responders, and Healthcare Workers Read More »

Scroll to Top